If there is any information that you would like included on this page please contact Alexandra Fullem (alexfullem@gmail.com). The website is updated approximately twice a month.
PDP Press Releases/ statements
• 29 Mar: World Vaccine Congress highlights IAVI’s R&D from end to end
• 17 Apr: New Nets Prevent 13 Million Malaria Cases in Sub-Saharan Africa
• 24 Mar: Commitment, Innovation and Action are Needed to End TB — On World TB Day, We Reaffirm our Dedication to all Impacted by Tuberculosis
• 25 Mar: Australian Government Grants TB Alliance an Award to Help Bolster Clinical Research and Improve Access to New Treatments for Drug-Resistant TB
• 25 Mar: New PeerLINC Knowledge Hub will Leverage Local Expertise and Experience to Accelerate New, More Effective TB Cures Around the World
• 24 Mar: World Tuberculosis Day 2024– We can End TB!
• 12 Mar: GARDP and Google DeepMind collaborate to accelerate target assessment
• 25 Mar: PATH concerned about funding cuts to global health security in US budget deal
• 25 Mar: New partnership aims to improve immunization efforts in conflict-afflicted and under immunized settings
• 17 Apr: Medicines for Malaria Venture appoints new CEO
• 24 Apr: MMV unveils its 2024–2030 business plan at MIM Society Conference, Rwanda
• 24 Apr: Medicines for Malaria Venture and Novartis announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
• 25 Apr: The Australian Government announces funding for MMV
• 3 Apr: DNDi signs memorandum of understanding with Kenya Medical Research Institute
• 23 Apr: Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
• 28 Mar: 2023 R&D portfolio in review: Hepatitis C
• 28 Mar: 2023 R&D portfolio in review: Sleeping sickness
• 28 Mar: 2023 R&D portfolio in review: Filaria – river blindness
• 28 Mar: 2023 R&D portfolio in review: Dengue
• 28 Mar: 2023 R&D portfolio in review: Pandemic preparedness
• 5 Apr: Global deployment of rapid diagnostic tests to boost fight against cholera
PDP Funder Announcements
• 12 Apr: Ahead of World Chagas Day, Unitaid reiterates its commitment to fighting Chagas disease. Unitaid
• 16 Apr: Unitaid and Expertise France announce the launch of Phase II of the SUCCESS program for the elimination of cervical cancer in ten low-resource countries. Unitaid
• 17 Apr: New Nets Prevent 13 Million Malaria Cases in Sub-Saharan Africa. Unitaid
• 23 Apr: New Unitaid report shows manufacturing antimalarials in Africa is critical to fighting malaria. UNITAID
• 25 Apr: UK improves access to life-saving malaria drugs. UK Government
• 24 Mar: Investing in the next generation of Tuberculosis treatment. Austrailian Ministry of Foreign Affairs
• 24 Mar: World TB Day 2024: Funding innovative research to end TB. EDCTP
• 27 Mar: Who loses when scientific research is locked behind paywalls?. Bill & Melinda Gates Foundation
Funder Announcement Archives
• 2014 PDP Funder Announcements
• 2013 PDP Funder Announcements
New PDP Publications
• 25 Apr: Rethinking antibodies for infectious diseases?. IAVI
Other Reports/ Publications
• Mar 5: 2023 TB Pipeline Report. TAG
• Mar 14: Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World. GHTC
Related Press Releases/ Announcements/ non-Peer Reviewed Articles
• 1 Apr: 'Pathogen prospecting': Mosquito researchers track malaria's history by examining its epidemiology. MedicalXpress
• 1 Apr: Impact with equity: EDCTP and equitable research partnerships. The Lancet Global Health
• 1 Apr: New report on HIV drug resistance: Challenges and recommendations. News Medical
• 2 Apr: Malaria vaccine rollout shines light on value of renewable power. Reuters
• 2 Apr: Africa now has momentum on TB; let’s not squander it. The Nation
• 2 Apr: Mpox: Is the World Failing the Next Pandemic Preparedness Litmus Test?. Health Policy Watch
• 2 Apr: Molecular biology technique allows for discovery of novel targets for candidate vaccines against schistosomiasis. Phys.org
• 2 Apr: From equitable access to equitable innovation: rethinking bioengineering for global health. Nature Bioengineering
• 2 Apr: New malaria vaccine strain shows promise in preclinical trials. News Medical
• 2 Apr: Advances in HIV treatment for adolescents: Are long-acting injectables the future?. Healio
• 2 Apr: Bavarian Nordic announces commercial launch of mpox vaccine. CIDRAP
• 2 Apr: Expanding Access to Long Acting HIV Prevention and Treatment Through Mobile Pharmacies. O’Neil Institute
• 3 Apr: Health As a Driver of Innovation Not Just a Recipient. Health Policy Watch
• 3 Apr: How the next wave of vaccines could target human parasites. Gavi
• 3 Apr: Experimental Ebola vaccines found safe and capable of producing immune responses in healthy adults. NIAID Blog
• 3 Apr: As AI proliferates, biopharma companies seek to harness it in clinical trials. STAT
• 3 Apr: New discovery unravels malaria invasion mechanism. Phys.org
• 3 Apr: Cepheid awarded WHO prequalification for extended coverage of point-of-care HIV test. 360Dx
• 3 Apr: Amid the escalating impact of antimicrobial resistance, the Global Leaders Group calls on UN Member States to take bold and specific action. Global Leaders Group on Antimicrobial Resistance
• 3 Apr: Interventions to address antimicrobial resistance: an ethical analysis of key tensions and how they apply in low- income and middle-income countries. BMJ Global Health
• 4 Apr: Will the Gates Foundation’s preprint-centric policy help open access?. Nature
• 4 Apr: First-generation malaria vaccine successfully implemented in three African countries. The Lancet
• 4 Apr: Drug prices soar after pharma giants GSK and Sanofi exit Nigeria. Devex
• 4 Apr: Thinking beyond diagnostic accuracy to evaluate tuberculosis screening tests. The Lancet Global Health
• 4 Apr: Point-of-care C-reactive protein and Xpert MTB/RIF Ultra for tuberculosis screening and diagnosis in unselected antiretroviral therapy initiators: a prospective, cross-sectional, diagnostic accuracy study. The Lancet Global Health
• 4 Apr: Tuberculosis screening in adults with HIV: beyond symptoms. The Lancet Global Health
• 4 Apr: Climate change: A driver of increasing vector-borne disease transmission in non-endemic areas. PLOS Medicine
• 4 Apr: Eight recommendations to shape the future of immunisation. Gavi
• 4 Apr: Tinubu to Gavi CEO: Nigerian manufacturers capable, ready to produce vaccines. Vanguard News
• 4 Apr: First-generation malaria vaccine successfully implemented in three African countries. The Lancet
• 5 Mar: Dengue is raging in Brazil. A promising local vaccine is at least a year away. Science
• 5 Apr: India’s newly amended patent rules threaten affordable medicines in the Global South. People’s Dispatch
• 5 Apr: Nigerians vaccinated in maiden Lassa fever vaccine clinical trial. The Guardian Nigeria
• 5 Apr: Nigeria needs to create investment environment for vaccine production — GAVI. Nigerian Tribune
• 5 Apr: Developing Countries Call for a Review of the TRIPS Agreement at the WTO. Geneva Health Files
• 5 Apr: To end TB, invest in drug discovery in and for Africa. The Independent Uganda
• 5 Apr: World Health Day: new technologies to accelerate action for global health. Institute of Development Studies
• 6 Mar: After decades of failures, researchers have renewed hopes for an effective HIV vaccine. NBC News
• 6 Mar: Merck-Gilead's weekly HIV combo maintains viral suppression, but it's early days for primary endpoint. Fierce Biotech
• 6 Mar: Long-acting HIV treatment benefits adults with barriers to daily pill taking and adolescents with suppressed HIV. NIAID
• 7 Mar: New study finds the malaria parasite generates genetic diversity using an evolutionary 'copy-paste' tactic. Phys.org
• 7 Apr: Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance. News Medical
• 7 Mar: Africa CDC announces spate of appointments in wake of deputy departure. Devex
• 7 Mar: What makes a pathogen antibiotic-resistant?. EureakAlert
• 7 Mar: Devex CheckUp: What Africa CDC wants from the pandemic treaty. Devex
• 8 Mar: Chlamydia-like 'parrot fever' won't be the next bird flu pandemic, experts say. BBC
• 8 Apr: UK researchers develop new tuberculosis testing method. 360Dx
• 8 Apr: Inside the push to make intellectual property work for African pharma. Devex
• 8 Apr: GAVI Alliance initiates $1b programme to boost vaccine production in Africa. The Guardian Nigeria
• 9 Apr: AI can help to tailor drugs for Africa — but Africans should lead the way. Nature
• 9 Apr: CEPI talks the need for speed when it comes to equitable vaccine access. BioProcess International
• 9 Apr: Comparison of Three Regional Medicines Regulatory Harmonisation Initiatives in Africa: Opportunities for Improvement and Alignment. IJHPM
• 9 Apr: Open letter from the biopharmaceutical industry to G20 Ministers in support of the advancement of the G20 Health Agenda. IFPMA
• 10 Apr: New Dengue Vaccine Trials Show Promise in Brazil as Cases Continue to Rise. Health Policy Watch
• 10 Apr: Amid Global Cholera Surge, Gavi Launches New Testing Programme. Health Policy Watch
• 10 Apr: Noma is a truly devastating tropical disease – more people need to know about it. Gavi
• 10 Apr: Oxford University and Brazil partner to advance malaria vaccine development. News Medical
• 11 Apr: 'World’s most comprehensive' health database opens to LMIC researchers. Devex
• 11 Apr: Is brain drain limiting Africa’s genomics potential?. Devex
• 11 Apr: Ending “domestic helicopter research”. Science Direct
• 11 Apr: Moderna puts plans for African vaccine plant on hold. The Financial Times
• 11 Apr: African Nations Have Agreed A Plan To Increase Locally Produced Vaccines. This Is How It Will Work. Africa.com
• 11 Apr: Exclusive: Concerned About an Unrealistic Deadline to Conclude a Pandemic Agreement, Some Countries Now Seek an Alternative Face-Saving Solution. Geneva Observer
• 11 Apr: Study highlights global rise in drug-resistant priority pathogens. CIDRAP
• 11 Apr: The push for a better dengue vaccine grows more urgent. The New York Times
• 11 Apr: Facing uncertain vaccine demand, Moderna halts mRNA plant buildout in Kenya. Fierce Pharma
• 11 Apr: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis. WHO
• 11 Apr: A new tool for accelerating tuberculosis vaccine development. The Lancet Infectious Diseases
• 12 Apr: Expanding options of child-friendly, single-tablet regimens for young children with HIV. The Lancet HIV
• 12 Apr: In world first, Nigeria introduces new 5-in-1 vaccine against meningitis. WHO
• 12 Apr: Asia-Pacific gets new weapon in fight against drug-resistant TB. France 24
• 12 Apr: Localization ‘lagging’ on bulk procurement, says USAID chief. Devex
• 13 Apr: Communiqué: United in the Fight Against Mpox in Africa – High-Level Emergency Regional Meeting. Africa CDC
• 14 Apr: USAID awards $45m to advance NTD research. My Joy Online
• 14 Apr: Every year, tuberculosis kills over a million people. Can a new vaccine turn the tide?. Vox
• 14 Mar: How CEPI and its partners are using AI to prepare for 'Disease X'. Devex
• 14 Mar: Study spotlights high incidence of typhoid fever in sub-Saharan Africa. CIDRAP
• 14 Mar: Healthy humans will be deliberately infected with Covid in bid to develop nasal spray vaccine. The Telegraph
• 14 Apr: Breakthrough aerosol human infection model gives hope for future tuberculosis vaccine development. University of Oxford
• 15 Apr: Latest results confirm malaria vaccine in Kenya safe. The Star
• 15 Apr: Facilitating the development of urgently required combination vaccines. The Lancet Global Health
• 15 Apr: Principles to Guide the Pathogen Access-and-Benefit Sharing System [PABS] in a Pandemic Agreement; Update: Proposal to Buy More Time to Operationalize PABS by May 2026. Geneva Health Files
• 15 Apr: Nigeria Becomes First Country in World to Roll out New Five-in-One Meningitis Vaccine. Health Policy Watch
• 15 Apr: African-led clinical research needs pharma buy-in. SciDevNet
• 15 Apr: Africa CDC calls out Moderna for 'abandoning' vaccine equity commitment. Devex
• 15 Apr: Netherlands and WHO forge stronger partnership in global health agenda. News Medical
• 15 Apr: Africa CDC’s Statement on Moderna’s plan to reassess commitment to African vaccine manufacturing. Africa CDC
• 16 Apr: Africa CDC faults Moderna decision on Kenya vaccine plant. Business Daily
• 16 Apr: Biden administration announces new partnership with 50 countries to stifle future pandemics. STAT
• 16 Apr: African-led clinical research essential to tackling the continent's health care challenges, says expert. MedicalXpress
• 16 Apr: World Health Assembly is Likely to See Basic ‘Consensus’ Pandemic Agreement as Hard Decisions are Deferred. Health Policy Watch
• 16 Apr: EXCLUSIVE: Next Draft of The Pandemic Agreement Will Likely Have No Fund and No Binding Obligations On Pathogen Access & Benefits Sharing, Defers Modalities to Conference of Parties. Geneva Health Files
• 16 Apr: New malaria vaccine shows promise: P. falciparum parasite attenuated by dual gene deletion. BioWorld
• 16 Apr: Plans to expand African vaccine production face steep hurdles. Science
• 17 Apr: White House releases new global health security strategy. CIDRAP
• 17 Apr: WHO prequalifies simplified version of oral cholera vaccine. CIDRAP
• 17 Apr: GSK announces promising data for gonorrhea treatment. CIDRAP
• 17 Apr: Second-generation mosquito nets prevented 13 million malaria cases in large pilot programs. STAT
• 17 Apr: Long-acting drugs may revolutionize HIV prevention and treatment. The New York Times
• 17 Apr: Latest Pandemic Agreement Draft Keeps Equity Hopes Alive – But Defers Key Operational Decisions. Health Policy Watch
• 18 Apr: CARB-X funds development of rapid, affordable gonorrhea test. CIDRAP
• 18 Apr: Gavi and UNICEF welcome approval of new oral cholera vaccine. Gavi
• 18 Apr: Chris Oyakhilome: Nigerian pastor pushing malaria vaccine conspiracy theories. BBC
• 18 Apr: New types of mosquito bed nets could cut malaria risk by up to half, trial finds. The Guardian
• 18 Apr: Millions of Girls in Africa Will Miss HPV Shots After Merck Production Problem. The New York Times
• 18 Apr: Pandemic Negotiations: ‘Hopeful and Scary Times’. Health Policy Watch
• 18 Apr: Drugs that aren’t antibiotics can also kill bacteria − new method pinpoints how. Gavi
• 18 Apr: Here’s what the pandemic treaty could achieve in May. Devex
• 18 Apr: New pandemic plan’s a lot like the old one. Politico
• 18 Apr: Bacteria found in mosquito guts could help scientists fight dengue, Zika. Science
• 18 Apr: After coming up short in COVID, Valneva focuses on chikungunya vaccine launch. Fierce Pharma
• 18 Apr: The path to a better tuberculosis vaccine runs through Montana. KFF News
• 19 Apr: Will new global health rules help make the world safer?. Devex
• 19 Apr: Pressure Builds On Countries To Embrace Weak Pandemic Agreement, Operationalizing Equity at Risk with a Framework Approach. Geneva Health Files
• 20 Mar: TB Vaccine Phase 3 Trial Launched, as WHO Makes Case for Investing in Screening and Prevention. Health Policy Watch
• 20 Apr: The Implementation of a Malaria Vaccine in Cameroon. Borgen Magazine
• 20 Mar: Innovative use of long-acting injectables holds promise for people with adherence challenges. POZ
• 21 Mar: Everyone wants to stop the next pandemic. But do they want to pay for it?. Devex
• 21 Mar: Local doesn't mean low cost: Serum Institute shares global scale-up plans. Devex
• 21 Mar: Closing diagnostic gaps to achieve parity in women’s healthcare. PLOS Blogs
• 21 Mar: Pharma Pivot on Pandemic Agreement: ‘Free Access’ to Pathogens in Exchange for ‘Binding Obligation’ on Equity. Health Policy Watch
• 21 Mar: Fight Against TB Gets Boost From Artificial Intelligence and Innovative Financing. Health Policy Watch
• 21 Mar: WHO publishes new guidance recommending targeted NGS for drug-resistant TB diagnosis. 360Dx
• 21 Mar: Amidst spreading infectious diseases and climate change, US FDA should renew its focus on neglected tropical diseases. PLOS Neglected Tropical Diseases
• 21 Mar: Are New Tuberculosis Vaccines Really Needed. Precision Vaccinations
• 22 Apr: Two new malaria vaccines are being rolled out across Africa: how they work and what they promise. The Conversation
• 22 Apr: Opinion: Why the silence on the shortfall in malaria vaccine doses?. Devex
• 22 Apr: Sierra Leone anticipates imminent immunisation campaign against malaria, the country’s number one child killer. Gavi
• 22 Apr: Praise and Criticism as Talks to Amend International Health Rules Near Conclusion. Health Policy Watch
• 22 Apr: R21/Matrix-M malaria vaccine: Evidence to recommendations framework, 2023. WHO
• 22 Apr: Evidence to Recommendation table: RTS,S/AS01 Malaria Vaccine, 2023. WHO
• 22 Mar: Effect of single-dose, live, attenuated dengue vaccine in children with or without previous dengue on risk of subsequent, virologically confirmed dengue in Cebu, the Philippines: a longitudinal, prospective, population-based cohort study. The Lancet Infectious Diseases
• 22 Mar: The epidemiology, transmission, diagnosis, and management of drug-resistant tuberculosis—lessons from the South African experience. The Lancet Infectious Diseases
• 22 Mar: 10 years after the 2014–16 Ebola epidemic in west Africa: advances and challenges in African epidemic preparedness. The Lancet
• 23 Apr: A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial. BMC Medicine
• 23 Apr: Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show. News Medical
• 23 Apr: “I’ve had enough of witnessing despair”: relief and hope greet Benin’s malaria vaccine roll-out. Gavi
• 24 Apr: R21 anti-malaria vaccine is a game changer: scientist who helped design it reflects on 30 years of research, and what it promises. The Conversation
• 24 Apr: Liberia Launches Anti-Malaria Vaccine for Children 5-18 Months Today. All Africa
• 24 Apr: Decolonising global health research: Shifting power for transformative change. PLOS Global Public Health
• 24 Apr: I study how genomics and the environment influence the spread of malaria. Nature
• 24 Apr: Africa CDC launches initiatives to advance molecular diagnostics and genomic surveillance in Africa. Africa CDC
• 25 Apr: Climate change is bringing malaria to new areas. In Africa, it never left. The Washington Post
• 25 Apr: Malaria is still killing people in Kenya, but a vaccine and local drug production may help. ABC News
• 25 Apr: Malaria research efforts converge at the Doherty Institute. The Doherty Institute
• 25 Apr: Two new malaria vaccines are being rolled out across Africa — how they work and what they promise. The Hindu
• 25 Apr: Willingness to accept malaria vaccines amongst women presenting at outpatient and immunization clinics in Enugu state, Southeast Nigeria. Malaria Journal
• 25 Apr: Kenya: Local anti malaria drug production signals progress. Africa News
• 25 Apr: Malaria fight: Scientists shift focus to vaccine, GMO mosquitoes. The Monitor
• 25 Apr: Colombia Issues Compulsory License to Enable it to Access Generic HIV Drug, Dolutegravir. Health Policy Watch
• 25 Apr: Unlocking the Potential of Pharmacogenomics in Africa. Health Policy Watch
• 25 Apr: Vaccines are a glimmer of hope against malaria, but the battle has only just begun. The Telegraph
• 25 Apr: Major step in malaria prevention as three West African countries roll out vaccine. WHO
• 25 Apr: How Innovative Partnerships Accelerated Access to New Malaria Tools. Think Global Health
• 25 Apr: Three More African Nations Roll Out Malaria Vaccine. Barron’s
• 25 Apr: Could humankind eliminate malaria for good?. Devex
• 25 Apr: Malaria experts call for action on growing drug resistance in Africa. Gavi
• 25 Apr: Harnessing the potential of African youth for transforming health research in Africa. Globalisation & Health
• 25 Apr: Cost of developing new drugs may be far lower than industry claims, trial reveals. The Guardian
• 25 Apr: FHI 360 and partners introduce injectable HIV prevention method as part of research study. FHI 360
• 25 Apr: How Rwanda is fighting malaria in a lab. Devex
• 27 Mar: WHO launches CoViNet: a global network for coronaviruses. WHO
• 28 Mar: High risk, high reward: Gavi's investment in Africa vaccine production. Devex
• 27 Apr: Moderna stalls on African vaccine manufacturing plans. The Lancet
• 28 Mar: Pandemic (Dis) Agreement Talks Limp into Extra Time. Health Policy Watch
• 28 Mar: WHO Member States agree to resume negotiations aimed at finalizing the world’s first pandemic agreement. WHO
• 29 Mar: Serum Institute’s argument against local manufacturing. Devex
• 30 Mar: How undetected tuberculosis is growing across Africa. Daily Monitor
Upcoming Meetings/ Webinars
--------------------------